02 May 2003
A mechanism for PARP-1 activation based on modeling studies of a ‘gain of function’ mutation
C. Patel, M. OliveiraMed Sci Monit 2003; 9(1): 54-0 :: ID: 15118
Abstract
PARP-1 is 113kDa natural biosensor whose activity increases 500 fold upon recognition of single strand break recognition. DNA binding by the N-terminal zinc finger domains triggers activation of the ADP-Ribose polymerization at the C-terminal end. Current PARP-1 inhibitors target a highly conserved nicotinamide pocket found in ADP-Ribosyl transferase (ADPRT) domain, which is present in all the members of the PARP family, thus they lack selectivity. Therapeutic benefits for PARP-1 inhibitors have only been shown in the selective PARP-1 knockout mouse. We have decided to investigate the allosteric activation of PARP-1 as a tool in the design of selective inhibitors. For this purpose we have focused on understanding the structural basis for a PARP-1 ‘gain of function’ mutation, L713F, which is reported to increase kcat/KM by ~9 fold. We have used the program InsightII to model human PARP-1, based on the known structure of the chicken catalytic fragment of PARP-1 (CF-PARP-1) and generated a model for L713F. The structure was energy minimized and molecular dynamics was utilized as a tool to investigate the flexibility of this two domain structure. The position L713F is found in the fourth helix of the all alpha helix domain of CF-PARP-1 ~3.0A away from the interface with the ADPRT domain. The structural changes due to the mutation are confined to a 4A radius of the mutation site. Our analysis suggests a mechanism for activation.References: 1.Alvez-Miranda, Dantzer F, O’Farrel M, de Murcia G, Menissier-de Murcia: Biochem Biophys Res Commun, 212, 317-325
Keywords: poly(ADP-ribose) polymerase-1, PARP-1, activation mechanism
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952